Skip to main content

ORBIMED ADVISORS LLC

Position in DYN — Dyne Therapeutics, Inc.

CIK 1055951 New York, NY

Position in DYN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$52,901,236
+$9,826,517 QoQ
Shares Held
2,917,884
+32.5% QoQ
Ownership
2.04%
of shares outstanding
% of Portfolio
1.07%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
14 quarters on record
Voting authority Sole 33.4591779522421.ToString("F0")% Shared 0.ToString("F0")% None 66.5408220477579.ToString("F0")%

Common Shares in DYN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

ORBIMED ADVISORS LLC holds $2,871,604,021 across 72 Biotechnology names. DYN ranks #16 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DYN

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $52,901,236 2,917,884
2025-12-31 $43,074,719 2,202,184
2025-09-30 $29,274,427 2,314,184
2025-06-30 $9,818,928 1,031,400
2025-03-31 $10,612,831 1,014,611
2024-12-31 $28,910,004 1,227,080
2024-09-30 $25,445,728 708,400
2024-06-30 $24,999,436 708,400
2024-03-31 $20,111,476 708,400
2022-09-30 $2,799,080 220,400
2021-06-30 $7,364,000 350,000
2021-03-31 $5,435,500 350,000
2020-12-31 $7,350,000 350,000
2020-09-30 $7,066,500 350,000